Latest Actavis Stories
RALEIGH, N.C., Nov.
- Transaction Valued at $66 Billion or $219 per Share in Cash and Actavis Shares - DUBLIN and IRVINE, Calif., Nov. 17, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Allergan, Inc.
- Expertise in global finance, M&A, business development - DUBLIN, Nov.
DUBLIN, Nov. 5, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that Chief Financial Officer R.
- Increases Second Half Non-GAAP EPS Forecast to $6.60-$6.70 - DUBLIN, Nov.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.